Exentis Group AG, provider of the world’s only 3D technology platform for large-scale industrial manufacturing, is preparing for its IPO, with a market potential of approximately CHF 200 billion as determined by Roland Berger. This potential extends to Pharma & MedTech, New Energy and Ultrafine Structures.
In order to optimally tap this potential, the previous business development function has been split. Customer interests are now represented by the Chief Commercial Officer and the Chief Product Officer. Michael Leitner, who has led Virgin Pulse’s global sales and customer support business, will assume the role of Chief Commercial Officer. He will focus on supporting the Exentis 3D community, expanding business with distributors, and direct sales.
Dr. Srdan Vasic, former Chief Technology Officer and instrumental in the development of the 3D technology platform, will become Chief Product Officer. Customers can thus be sure to receive their applications quickly and in high quality.
Dr. Gereon Heinemann, Chief Executive Officer of Exentis Group AG: “I am very pleased that we have been able to win Michael Leitner, a proven sales and digitalization expert, for Exentis. In particular, Mr. Leitner will be responsible for and implement Additive-Manufacturing-as-a-Service (AMaaS) as part of the increased digitalization of our business model. In addition to our digital global service platform for optimal support of existing customers, we are thus also expanding our cloud-based services to include new customer acquisition.”
The structural changes at Exentis are intended to strengthen the company’s position in the field of industrial 3D printing technology. With an identified market potential of CHF 200 billion and new leadership positions, Exentis is well positioned to expand in the pharmaceutical, new energy and ultra-fine structures sectors.
Subscribe to our Newsletter
3DPresso is a weekly newsletter that links to the most exciting global stories from the 3D printing and additive manufacturing industry.
